Doral, FLNCT07780669Now EnrollingIRB Ready

Pulmonary Disease, Chronic Obstructive Clinical Trial in Doral, FL

Access cutting-edge pulmonary disease, chronic obstructive treatment through this phase 3 clinical trial at a research site in Doral. Study-provided care at no cost to qualified participants.

Sponsored by GlaxoSmithKline

Quick Self-Assessment

See if you qualify for this Doral location

Preparing your pre-screening questions…

Expert Care in Doral

Access pulmonary disease, chronic obstructive specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pulmonary disease, chronic obstructive treatment provided free

Apply for This Doral Location

Check if you qualify for this pulmonary disease, chronic obstructive clinical trial in Doral, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Doral

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Doral site if eligible
  4. 4Begin participation

About This Pulmonary Disease, Chronic Obstructive Study in Doral

The study primarily aims to demonstrate the superiority of GSK5784283 as an add-on therapy compared to placebo in reducing the annualized rate of moderate and severe chronic obstructive pulmonary disease (COPD) exacerbations.

Sponsor: GlaxoSmithKline

Who Can Participate

Inclusion Criteria

Male or eligible female participants
Participants with \>=40 to less than or equal to (\<=) 80 years of age.
An eosinophilic phenotype with elevated BEC.
Moderate to very severe COPD with frequent exacerbations.
Participants with elevated COPD assessment test (CAT) score.
Current or former cigarette smokers.
On triple (Inhaled corticosteroid \[ICS\]+ Long-acting muscarinic antagonist \[LAMA\]+ Long-acting beta-agonist \[LABA\]) or dual inhaled COPD therapy, if ICS is considered not appropriate.

Exclusion Criteria

Current or prior physician diagnosis of asthma
Other clinically significant lung disease.
Pneumonia, COPD exacerbation, or lower respiratory tract infection within the 4 weeks prior to Screening Visit 1.
Participants with a history of, or plan for lung volume reduction surgery / endobronchial valve procedure.
Continuous oxygen therapy (more than 16 hours/ day).
Cor pulmonale resulting in right heart failure and severe pulmonary hypertension.
A current malignancy or history of malignant neoplasm within the last 5 years (except definitively treated non-melanoma skin cancer or carcinoma in situ of the uterine cervix).
Myocardial infarction, unstable angina or stroke within 6 months of screening, unstable arrhythmia.
New York Heart Association class III or IV heart failure.
Other significant medical conditions that could impact participants' safety or study outcomes.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Doral?

Yes, this clinical trial (NCT07780669) has an active research site in Doral, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pulmonary Disease, Chronic Obstructive Treatment Options in Doral, FL

If you're searching for pulmonary disease, chronic obstructive treatment options in Doral, FL, this clinical trial (NCT07780669) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Doral research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced pulmonary disease, chronic obstructive specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pulmonary disease, chronic obstructive clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Doral, FL

See all ulcerative colitis clinical trials recruiting in Doral — not just this study.

Browse Ulcerative Colitis Trials in Doral →

Browse More Trials by Condition

Ulcerative Colitis TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Doral?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Doral, FL